Physician profile
Allison M Arthur
NPI 1639166002
$871.46
in general payments reported to CMS, 2019-2025
13 companies · $95.23 in 2025
The $95.23 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2021: $79.66 · 2022: $119 · 2023: $235 · 2024: $199 · 2025: $95.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $205.72 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $160.37 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $108.54 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $98.43 | 2019-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Cranial Technologies, INC | $73.17 | 2019-2025 | Doc Band |
| Pfizer INC. | $58.70 | 2019-2025 | |
| Insulet Corporation | $38.23 | 2021 | |
| Biomarin Pharmaceutical INC. | $26.68 | 2024 | Voxzogo 1.2mg |
| Sobi, INC | $24.74 | 2019 | |
| Shire North American Group INC | $21.92 | 2019 | |
| Sanofi Pasteur INC. | $21.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $20.63 | 2023 | |
| Neos Therapeutics, LP | $13.29 | 2024 | Cotempla Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.